Shasqi will be presenting two posters on the CAPAC platform at this year's event.
The first, entitled: Attenuated MMAE therapeutic activated by click chemistry at the tumor evokes potent immune responses highlights the therapeutic potential of SQP22, a clickable payload of MMAE.
A second, entitled: Doxorubicin-based click chemistry therapeutic activates potent cytotoxic immune responses in advanced sarcoma patients in a Phase 1/2a clinical trial, shows the immune impact of high dose doxorubicin administration facilitated by CAPAC.
